MAI Shuyi (麥淑儀)

Research Output

  1. 2021
  2. Accepted/In press/Filed

    Drug And GEne Therapy to Treat High Myopia And Other Ocular Disorders with Enlarged Eye Globes

    MAI, S. & XIONG, W., 11 Jun 2021, (Accepted/In press/Filed) Priority No. 17/346,036

    Research output: Patents, Agreements and Assignments (RGC: 51, 52, 53)51_Patents granted (CityU only, data source from KTO)

    Check@CityULib
  3. 2020
  4. Published

    Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice

    Feng, T., Mai, S., Roscoe, J. M., Sheng, R. R., Ullah, M., Zhang, J., Katz, I. I. & 3 others, Yu, H., Xiong, W. & Hu, F., 5 Oct 2020, In: EMBO Reports. 21, 10, e50219.

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 11
    Check@CityULib
  5. 2018
  6. Published

    AAV-mediated overexpression of nuclear SREBP1/2 induces buphthalmos and retinal degeneration in mice

    MAI, S., Wu, D. M., Kizhatil, K., John, S. W., Cepko, C. L. & Xiong, W., Apr 2018.

    Research output: Conference Papers (RGC: 31A, 31B, 32, 33)Poster

    Check@CityULib